• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症:支持治疗、组织和研究的前沿。

Sepsis: frontiers in supportive care, organisation and research.

机构信息

Department of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

St. George's Healthcare NHS Trust, St George's University of London, London, UK.

出版信息

Intensive Care Med. 2017 Apr;43(4):496-508. doi: 10.1007/s00134-017-4677-4. Epub 2017 Jan 27.

DOI:10.1007/s00134-017-4677-4
PMID:28130686
Abstract

Because of its high incidence and clinical complexity, sepsis is a major challenge to clinicians and researchers and a global burden to healthcare systems and society. Despite recent progress, short- and long-term morbidity, mortality and costs remain high in both developed and developing countries. Thus, further improvements in supportive interventions and organisation of care are likely to have a substantial impact upon global health. In this narrative review, invited experts describe the challenges and progress to be made in sepsis research and care in the near future. We focus on supportive care (pulmonary, endocrine, renal, and nutritional support, mediator modulation and precision medicine), organisational themes (guidelines, outcome measures and stakeholder involvement) and clinical research as key areas to improving the care and outcomes of patients with sepsis.

摘要

由于其高发病率和临床复杂性,脓毒症是临床医生和研究人员面临的主要挑战,也是医疗保健系统和社会的全球性负担。尽管最近取得了进展,但在发达国家和发展中国家,短期和长期发病率、死亡率和成本仍然很高。因此,进一步改善支持性干预措施和护理组织可能会对全球健康产生重大影响。在这篇叙述性评论中,受邀专家描述了未来脓毒症研究和护理方面的挑战和进展。我们专注于支持性护理(肺部、内分泌、肾脏和营养支持、介质调节和精准医学)、组织主题(指南、结果测量和利益相关者参与)以及临床研究,作为改善脓毒症患者护理和结局的关键领域。

相似文献

1
Sepsis: frontiers in supportive care, organisation and research.脓毒症:支持治疗、组织和研究的前沿。
Intensive Care Med. 2017 Apr;43(4):496-508. doi: 10.1007/s00134-017-4677-4. Epub 2017 Jan 27.
2
Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy.败血症:诊断、复苏和抗生素治疗的新进展。
Intensive Care Med. 2016 Dec;42(12):1958-1969. doi: 10.1007/s00134-016-4577-z. Epub 2016 Oct 1.
3
The Economic and Humanistic Burden of Severe Sepsis.严重脓毒症的经济与人文负担
Pharmacoeconomics. 2015 Sep;33(9):925-37. doi: 10.1007/s40273-015-0282-y.
4
[Critical care research].[重症监护研究]
Ugeskr Laeger. 2007 Feb 19;169(8):677-9.
5
Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain.西班牙一项多中心严重脓毒症教育项目实施后护理过程及结局的改善
JAMA. 2008 May 21;299(19):2294-303. doi: 10.1001/jama.299.19.2294.
6
Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.脓毒性休克患儿血流动力学支持的时间和液体敏感性复苏:在发展中国家一家儿科重症监护病房实施美国危重病医学会/儿科高级生命支持指南的障碍
Pediatr Emerg Care. 2008 Dec;24(12):810-5. doi: 10.1097/PEC.0b013e31818e9f3a.
7
Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice.理解和改善脓毒症幸存者状况。研究和实践的优先事项。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):972-981. doi: 10.1164/rccm.201812-2383CP.
8
Surviving sepsis campaign in Brazil.巴西的拯救脓毒症运动。
Shock. 2008 Oct;30 Suppl 1:47-52. doi: 10.1097/SHK.0b013e318181a128.
9
Summary of NIH Medical-Surgical Emergency Research Roundtable held on April 30 to May 1, 2009.NIH 医疗-外科急诊研究圆桌会议总结,于 2009 年 4 月 30 日至 5 月 1 日举行。
Ann Emerg Med. 2010 Nov;56(5):522-37. doi: 10.1016/j.annemergmed.2010.03.014.
10
The recognition and management of sepsis and septic shock: a guide for non-intensivists.脓毒症和脓毒性休克的识别与管理:非重症医学科医生指南
Postgrad Med J. 2017 Oct;93(1104):626-634. doi: 10.1136/postgradmedj-2016-134519. Epub 2017 Jul 29.

引用本文的文献

1
Molecular Biomarkers and More Efficient Therapies for Sepsis.脓毒症的分子生物标志物与更有效的治疗方法
Biomedicines. 2025 Feb 14;13(2):468. doi: 10.3390/biomedicines13020468.
2
Aloe-emodin plus TIENAM ameliorate cecal ligation and puncture-induced sepsis in mice by attenuating inflammation and modulating microbiota.芦荟大黄素联合亚胺培南通过减轻炎症和调节微生物群改善小鼠盲肠结扎和穿刺诱导的脓毒症。
Front Microbiol. 2024 Dec 12;15:1491169. doi: 10.3389/fmicb.2024.1491169. eCollection 2024.
3
The protagonist of contemporary and emerging nanotechnology-based theranostics and therapeutic approaches in reshaping intensive care unit.

本文引用的文献

1
Sepsis and septic shock.脓毒症与脓毒性休克。
Nat Rev Dis Primers. 2016 Jun 30;2:16045. doi: 10.1038/nrdp.2016.45.
2
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域和国家249种死因的预期寿命、全死因死亡率和死因别死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
3
Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy.
基于当代和新兴纳米技术的治疗学和治疗方法的主角正在重塑重症监护病房。
Saudi Med J. 2024 Aug;45(8):759-770. doi: 10.15537/smj.2024.45.8.20240069.
4
TR4 worsen urosepsis by regulating GSDMD.TR4 通过调控 GSDMD 加重尿脓毒症。
Eur J Med Res. 2024 Mar 1;29(1):151. doi: 10.1186/s40001-024-01742-6.
5
The Clinical Value of Comprehensive Nursing Intervention in Preventing Severe Lymphopenia and Improving the Survival Rate Among Patients with Sepsis.综合护理干预在预防脓毒症患者严重淋巴细胞减少及提高生存率中的临床价值
Open Access Emerg Med. 2023 Oct 21;15:393-403. doi: 10.2147/OAEM.S433980. eCollection 2023.
6
Neutrophil extracellular traps contribute to immunothrombosis formation via the STING pathway in sepsis-associated lung injury.中性粒细胞胞外诱捕网通过STING通路促进脓毒症相关肺损伤中免疫血栓形成。
Cell Death Discov. 2023 Aug 25;9(1):315. doi: 10.1038/s41420-023-01614-8.
7
Less Severe Polymicrobial Sepsis in Conditional -Deleted Mice Using LysM-Cre System, Impacts of DNA Methylation and MGMT Inhibitor in Sepsis.条件性缺失 LysM-Cre 系统小鼠中严重程度较轻的多微生物性败血症,败血症中 DNA 甲基化和 MGMT 抑制剂的影响。
Int J Mol Sci. 2023 Jun 15;24(12):10175. doi: 10.3390/ijms241210175.
8
Less Severe Lipopolysaccharide-Induced Inflammation in Conditional -Deleted Mice with LysM-Cre System: The Loss of DNA Repair in Macrophages.条件性缺失 LysM-Cre 系统小鼠的脂多糖诱导炎症减轻:巨噬细胞中 DNA 修复的缺失。
Int J Mol Sci. 2023 Jun 14;24(12):10139. doi: 10.3390/ijms241210139.
9
Less Severe Sepsis in Cecal Ligation and Puncture Models with and without Lipopolysaccharide in Mice with Conditional -Deleted Macrophages (LysM-Cre System).条件性缺失巨噬细胞(LysM-Cre 系统)小鼠的盲肠结扎和穿刺模型中,脂多糖存在和不存在时,严重程度较低的败血症。
Int J Mol Sci. 2023 May 10;24(10):8517. doi: 10.3390/ijms24108517.
10
The role of nanotechnology-based approaches for clinical infectious diseases and public health.基于纳米技术的方法在临床传染病和公共卫生中的作用。
Front Bioeng Biotechnol. 2023 Apr 3;11:1146252. doi: 10.3389/fbioe.2023.1146252. eCollection 2023.
败血症:诊断、复苏和抗生素治疗的新进展。
Intensive Care Med. 2016 Dec;42(12):1958-1969. doi: 10.1007/s00134-016-4577-z. Epub 2016 Oct 1.
4
Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.氢化可的松对严重脓毒症患者休克发生的影响:HYPRESS随机临床试验
JAMA. 2016 Nov 1;316(17):1775-1785. doi: 10.1001/jama.2016.14799.
5
Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study.德国重症监护病房严重脓毒症和脓毒性休克的发生率:前瞻性、多中心 INSEP 研究。
Intensive Care Med. 2016 Dec;42(12):1980-1989. doi: 10.1007/s00134-016-4504-3. Epub 2016 Sep 29.
6
Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial.限制初始治疗后脓毒性休克成人复苏液量:CLASSIC 随机、平行组、多中心可行性试验。
Intensive Care Med. 2016 Nov;42(11):1695-1705. doi: 10.1007/s00134-016-4500-7. Epub 2016 Sep 30.
7
Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI).一项多中心随机对照试验的研究方案:重组人碱性磷酸酶在脓毒症相关性急性肾损伤患者中的安全性、耐受性、疗效及生活质量(STOP-AKI研究)
BMJ Open. 2016 Sep 27;6(9):e012371. doi: 10.1136/bmjopen-2016-012371.
8
The Effect of High-Flow Nasal Cannula Oxygen Therapy on Mortality and Intubation Rate in Acute Respiratory Failure: A Systematic Review and Meta-Analysis.高流量鼻导管给氧疗法对急性呼吸衰竭患者死亡率和插管率的影响:一项系统评价和Meta分析
Crit Care Med. 2017 Apr;45(4):e449-e456. doi: 10.1097/CCM.0000000000002091.
9
Patient Selection and Timing of Continuous Renal Replacement Therapy.连续性肾脏替代治疗的患者选择与时机
Blood Purif. 2016;42(3):224-37. doi: 10.1159/000448506. Epub 2016 Aug 26.
10
How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin.明胶的安全性如何?含明胶的血浆代用品与晶体液和白蛋白的系统评价与荟萃分析。
J Crit Care. 2016 Oct;35:75-83. doi: 10.1016/j.jcrc.2016.04.011. Epub 2016 Apr 23.